| Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
| |
| Device | SYNVISC & SYNVISC-ONE (HYLAN G-F 20) |
| Generic Name | Acid, hyaluronic, intraarticular |
| Applicant | Sanofi Genzyme Corp. 450 Water St. Cambridge, MA 02141 |
| PMA Number | P940015 |
| Supplement Number | S014 |
| Date Received | 02/17/2009 |
| Decision Date | 03/11/2009 |
| Product Code |
MOZ |
| Advisory Committee |
Orthopedic |
| Supplement Type | 30-Day Notice |
| Supplement Reason | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
| Recalls | CDRH Recalls |
Approval Order Statement REMOVAL OF THE CYTOTOXICITY TEST (USP<87> BIOLOGICAL REACTIVITY TEST, IN VITRO) FROM THE HYLAN B-10 GEL IN-PROCESS SPECIFICATION FOR THE DEVICE. |
|
|